Patch purveyors stock up for smoking ban
National drug companies often see a 30 percent to 50 percent spike in retail sales of nicotine patches and gum after a smoking ban goes into effect, said Jennifer May, a GlaxoSmithKline spokeswoman in Pittsburgh.
(This is the real reason Big Pharma pushes for these bans (usually quietly, behind the scenes). It has nothing to do with improving health. It’s all about seeing very profitable, highly ineffective quit-smoking aids.)
Source: The Denver Post. Link Expired.


